시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 괴사성 리포이드카(NL) 시장 보고서(2025년)
Necrobiosis Lipodica (NL) Global Market Report 2025
상품코드 : 1730958
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,648,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,609,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,571,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 괴사성 리포이드카 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 6.7%로 56억 5,000만 달러로 성장할 것으로 보입니다. 예측기간의 성장은 고령화 인구 증가, 피부 건강과 미용에 대한 의식 증가, 가처분 소득 증가, 피부의 건강에 대한 의식 증가, 정부 이니셔티브의 상승 등의 요인에 의해 초래됩니다. 이 기간에 예상되는 주요 동향으로는 치료 선택의 진보, 진단 기술의 향상, 생물 제제의 채용, 임상 검사의 진전, 재생 요법의 출현 등이 있습니다.

당뇨병의 이환율 증가는 향후 리포이드 괴사증(NL) 시장의 성장을 가속할 것으로 예측됩니다. 당뇨병은 인슐린 분비 부족과 인슐린 저항성으로 인해 신체가 혈당 조절에 어려움을 겪는 만성 질환으로 다양한 건강 합병증을 유발할 수 있습니다. 당뇨병 환자 증가는 앉기 쉬운 라이프 스타일, 식생활의 혼란, 유전적 소인에 의한 점이 큽니다. 신체 활동의 저하, 과도한 스크린 타임 등을 특징으로 하는 현대의 라이프 스타일은 비만과 인슐린 저항성을 조장하고 있습니다. 당뇨병으로 혈당이 높아지면, 가는 혈관에 장애가 일어나(미소혈관증), 혈행 불량, 산소의 감소, 피부에의 영양 공급의 저하를 초래합니다. 그 결과 피부가 부상을 입기 쉽고 치유가 지연됩니다. 그 결과 피부 조직이 변성되어 NL에 노란색 위축이 형성됩니다. 2023년 10월 국민보건서비스(National Health Service)의 보고에 따르면 잉글랜드에서 1형 당뇨병의 유병률은 2021년 26만 1,710건에서 2022년 27만 935건으로 증가하여 전년대비 3.5% 증가했습니다. 따라서 당뇨병 환자 수 증가는 괴사성 리포이드카 시장의 성장을 가속하고 있습니다.

자가면역 질환의 이환율 증가는 또한 괴사성 리포이드카 시장의 성장을 가속할 것으로 예측됩니다. 2024년 11월에 Versorgungsatlas가 발표한 바에 따르면 독일의 피보험자 7,324만 1,305명 중, 2022년에는 630만 4,340명이 적어도 하나의 자가면역질환으로 진단되었으며, 유병률은 8.61%였습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Necrobiosis lipoidica is a rare, chronic skin condition marked by yellowish, atrophic plaques with prominent blood vessels, most often appearing on the shins. It is associated with collagen degeneration, inflammation, and lipid accumulation within the skin.

The primary treatment options for necrobiosis lipoidica (NL) include therapies, medications, and other interventions. Therapy refers to treatments aimed at alleviating or healing the condition, often incorporating medical, psychological, or physical approaches. These treatments can be administered through various routes, including oral, topical, parenteral, and other methods. The diagnosis of NL is typically made using techniques such as skin biopsy, histopathology, and other diagnostic procedures. Treatments are distributed via channels such as hospital pharmacies, online pharmacies, and retail pharmacies. Additionally, the end users of these treatments include hospitals, home care settings, specialty clinics, and other healthcare providers.

The necrobiosis lipoidica (NL) market research report is one of a series of new reports from The Business Research Company that provides necrobiosis lipoidica (NL) market statistics, including the necrobiosis lipoidica (NL) industry global market size, regional shares, competitors with the necrobiosis lipoidica (NL) market share, detailed necrobiosis lipoidica (NL) market segments, market trends, and opportunities, and any further data you may need to thrive in the necrobiosis lipoidica (NL) industry. This necrobiosis lipoidica (NL) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The necrobiosis lipoidica market size has grown strongly in recent years. It will grow from $4.08 billion in 2024 to $4.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historical period can be attributed to factors such as the rising number of diabetes cases, the increasing prevalence of skin infections, higher healthcare spending, a growing incidence of cancer, and greater awareness of the disease.

The necrobiosis lipoidica market size is expected to see strong growth in the next few years. It will grow to $5.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The projected growth for the forecast period is driven by factors such as the increasing aging population, rising awareness of skin health and aesthetics, higher disposable incomes, growing awareness of skin health, and the rise of government initiatives. Key trends expected during this period include advancements in treatment options, improvements in diagnostic techniques, the adoption of biologics, progress in clinical trials, and the emergence of regenerative therapies.

The rising incidence of diabetes is expected to drive the growth of the necrobiosis lipoidica (NL) market in the future. Diabetes is a chronic condition where the body struggles to regulate blood sugar due to insufficient insulin production or insulin resistance, which can lead to various health complications. The increase in diabetes cases is largely attributed to sedentary lifestyles, poor diets, and genetic predisposition. Modern lifestyles, characterized by prolonged sitting, reduced physical activity, and excessive screen time, contribute to obesity and insulin resistance. High blood sugar levels in diabetes cause damage to small blood vessels (microangiopathy), which leads to poor circulation, reduced oxygen, and nutrient supply to the skin. This makes the skin more vulnerable to injury and delayed healing. As a result, skin tissue degenerates, contributing to the formation of yellowish, atrophic plaques in NL. For example, in October 2023, the National Health Service reported that the prevalence of Type 1 diabetes in England rose from 261,710 cases in 2021 to 270,935 cases in 2022, marking a 3.5% increase year-over-year. Therefore, the growing number of diabetes cases is fueling the growth of the necrobiosis lipoidica market.

The increasing incidence of autoimmune diseases is also expected to drive the growth of the necrobiosis lipoidica market. Autoimmune diseases occur when the body's immune system mistakenly attacks its own healthy cells and tissues. The rise in autoimmune diseases is influenced by factors such as genetic predisposition, environmental triggers, and lifestyle changes that affect immune system behavior. These diseases contribute to NL by causing chronic inflammation and immune dysfunction, which leads to collagen degeneration and impaired skin healing. For instance, in November 2024, Versorgungsatlas reported that, among 73,241,305 insured individuals in Germany, 6,304,340 were diagnosed with at least one autoimmune disease in 2022, resulting in a raw prevalence rate of 8.61%. This rising incidence of autoimmune diseases is driving the growth of the necrobiosis lipoidica market.

Leading companies in the necrobiosis lipoidica market are focusing on innovative solutions, such as developing websites for patient education, to enhance diagnosis, treatment accessibility, and disease management. Websites are digital platforms that provide information, services, or interactive features accessible via the internet. For example, in August 2022, Processa Pharmaceuticals, a US-based clinical-stage biopharmaceutical company, launched Necrobiosislipoidicastudy.com, a website designed to raise awareness about ulcerative necrobiosis lipoidica (uNL), a rare dermatological condition. The platform provides information on the ongoing Phase 2 clinical trial evaluating PCS499 as a potential treatment for uNL, furthering the company's commitment to advancing innovative therapies for underserved patient populations.

Major players in the necrobiosis lipodica (nl) market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Bausch Health Companies Inc., Galderma Laboratories L.P., Dr. Reddy's Laboratories Ltd., Incyte Pharmaceuticals, Celltrion Healthcare Co. Ltd., Almirall S.A., Samsung Bioepis Co. Ltd., Hovione, Momenta Pharmaceuticals Inc., HanAll Biopharma Co. Ltd., Processa Pharmaceuticals.

North America was the largest region in the necrobiosis lipoidica market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in necrobiosis lipoidica (NL) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the necrobiosis lipoidica (NL) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The necrobiosis lipoidica (NL) market consists of revenues earned by entities by provide services such as dermatology consultation, wound care services, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The necrobiosis lipoidica market includes sales of corticosteroids, immunomodulators, corticosteroid creams, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Necrobiosis Lipodica (NL) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on necrobiosis lipodica (nl) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for necrobiosis lipodica (nl) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The necrobiosis lipodica (nl) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Necrobiosis Lipodica (NL) Market Characteristics

3. Necrobiosis Lipodica (NL) Market Trends And Strategies

4. Necrobiosis Lipodica (NL) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Necrobiosis Lipodica (NL) Growth Analysis And Strategic Analysis Framework

6. Necrobiosis Lipodica (NL) Market Segmentation

7. Necrobiosis Lipodica (NL) Market Regional And Country Analysis

8. Asia-Pacific Necrobiosis Lipodica (NL) Market

9. China Necrobiosis Lipodica (NL) Market

10. India Necrobiosis Lipodica (NL) Market

11. Japan Necrobiosis Lipodica (NL) Market

12. Australia Necrobiosis Lipodica (NL) Market

13. Indonesia Necrobiosis Lipodica (NL) Market

14. South Korea Necrobiosis Lipodica (NL) Market

15. Western Europe Necrobiosis Lipodica (NL) Market

16. UK Necrobiosis Lipodica (NL) Market

17. Germany Necrobiosis Lipodica (NL) Market

18. France Necrobiosis Lipodica (NL) Market

19. Italy Necrobiosis Lipodica (NL) Market

20. Spain Necrobiosis Lipodica (NL) Market

21. Eastern Europe Necrobiosis Lipodica (NL) Market

22. Russia Necrobiosis Lipodica (NL) Market

23. North America Necrobiosis Lipodica (NL) Market

24. USA Necrobiosis Lipodica (NL) Market

25. Canada Necrobiosis Lipodica (NL) Market

26. South America Necrobiosis Lipodica (NL) Market

27. Brazil Necrobiosis Lipodica (NL) Market

28. Middle East Necrobiosis Lipodica (NL) Market

29. Africa Necrobiosis Lipodica (NL) Market

30. Necrobiosis Lipodica (NL) Market Competitive Landscape And Company Profiles

31. Necrobiosis Lipodica (NL) Market Other Major And Innovative Companies

32. Global Necrobiosis Lipodica (NL) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Necrobiosis Lipodica (NL) Market

34. Recent Developments In The Necrobiosis Lipodica (NL) Market

35. Necrobiosis Lipodica (NL) Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기